Dis-Chem outlines expansion strategy

Dis-Chem's reported a 39% plunge in half-year earnings, partly due to strike-related costs. The pharmacy group says this is the last set of results that will be impacted by the industrial action, and that it is now focused on gaining market share. CFO Rui Morais spoke to Business Day TV about Dis-Chem's expansion strategy, as well as the capital commitments the group has made regarding that.